Drug Related Testing Reagents Clinical Trial Analysis

Summary

Global Markets Direct's "Drug Related Testing Reagents Clinical Trials Analysis" is an essential source of data and information pertaining to product clinical trials being carried out by Drug Related Testing Reagents manufacturers, globally. The report provides exhaustive information on each clinical investigation study with coverage detailed coverage on the pipeline products these trials are being carried out for.

Scope

• The report provides analysis and review of the key clinical trials being carried out globally and across key Drug Related Testing Reagents market categories - Therapeutic Drugs,Drug of Abuse and Toxicology
• The report covers information on each product being clinically tested with detailed coverage on the pipeline product profile, the indication it's being investigated for etc.
• The report provides an in-depth analysis of the clinical trials with information on trial phase, trial 0status, trial acronym, purpose, inclusion and exclusion criteria, description, design, intervention, investigator information, primary and secondary end-points and trial results
• The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by Global Markets Direct's team of industry experts.

Reasons to Buy

• Effectively plan your Mergers and Acquisitions and partnership strategies by identifying companies with the most promising pipeline.
• Stay ahead of the information curve in the fast changing Drug Related Testing Reagents market.
• Plan in-licensing and out-licensing opportunities through review of pipeline products and technologies.
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
• Proactively plan and execute your competitive strategies by identifying clinical trials status of the leading competitive products in pipeline.
• Stay ahead of competition by understanding the changing competitive landscape in specific geographies.

Contents

• 1 List of Tables
• 1.2 List of Figures
• 2 Drug Related Testing Reagents Clinical Trials
  • 2.1 Drug Related Testing Reagents Clinical Trial By Equipment Type
  • 2.2 Drug Related Testing Reagents Clinical Trials By Trial Phase and Trial Status
  • 2.3 Drug Related Testing Reagents Pipeline Products By Development Stage
  • 2.4 Drug Related Testing Reagents Pipeline Products By Therapy Area
  • 2.5 Drug Related Testing Reagents Pipeline Products By News Summary
• 3 Recent Developments
  • 3.1 Product News
    • 3.1.1 May 13, 2009: Accumetrics Enrolls 1000th Patient Into GRAVITAS Trial
    • 3.1.2 May 01, 2009: Myriad Genetics' OnDose, The New Molecular Oncology Test Utilizes Patent Rights Licensed From Saladax
    • 3.1.3 Mar 18, 2009: Corgenix To Showcase AspirinWorks Test At American College Of Cardiology
    • 3.1.4 Feb 26, 2009: Trimgen Corporation's eQPCR LC Warfarin Genotyping Kit Selected For NIH-Sponsored Trial To Determine Clinical Significance
    • 3.1.5 Feb 18, 2009: TrimGen Corporation's eQ-PCR LC Warfarin Genotyping kit Receives FDA Approval
    • 3.1.6 Jan 14, 2009: FDA Grants 510(k) Clearance For QuantRx's RapidSense Phencyclidine (PCP) Test
    • 3.1.7 Jan 08, 2009: ParagonDx Launches Genetic Test For warfarin sensitivity
    • 3.1.8 Jan 06, 2009: QuantRx Biomedical Announces 510(k) Approval For Its RapidSense Methamphetamine Test
    • 3.1.9 Nov 19, 2008: Drger's DrugTest 5000 System Enables A Fast And Reliable Check For Suspected Drug Abuse
    • 3.1.10 Nov 11, 2008: Drger Offers Alcotest 7510 For Precise Measurement Of Breath Alcohol Concentrations
    • 3.1.11 Nov 10, 2008: Siemens Molecular Testing System Has New Operating System
    • 3.1.12 Nov 04, 2008: OraSure's Intercept Oral Fluid Drug Test Results Comparable To Urine Drug Screening According To Landmark Five-Year Analysis
    • 3.1.13 Aug 05, 2008: Saladax Biomedical Enters Agreement With Karolinska University Hospital To Supply 5-FU Personalized Chemotherapy Management Assay
    • 3.1.14 Aug 05, 2008: SpectraCell Laboratories Now Offers Aspirin Response Testing
    • 3.1.15 Jul 28, 2008: Corgenix Announces Collaboration With SpectraCell Laboratories
    • 3.1.16 Jul 21, 2008: Osmetech Announces Approval Of eSensor XT-8 Molecular Diagnostics Platform
    • 3.1.17 Jul 17, 2008: NicAlert Gains Acceptance In Clinical Trials And Research Studies: NicAlert Urine
    • 3.1.18 Jul 17, 2008: Nymox's NicAlert Gains Acceptance In Clinical Trials And Research Studies
    • 3.1.19 Jun 16, 2008: Accumetrics Announces The Launch And First Patient Enrolled Into The GRAVITAS Trial
  • 3.2 Product Approvals
    • 3.2.1 Feb 18, 2009: TrimGen Corporation's eQ-PCR LC Warfarin Genotyping kit Receives FDA Approval
    • 3.2.2 Jan 14, 2009: FDA Grants 510(k) Clearance For QuantRx's RapidSense Phencyclidine (PCP) Test
    • 3.2.3 Jan 06, 2009: QuantRx Biomedical Announces 510(k) Approval For Its RapidSense Methamphetamine Test
    • 3.2.4 Jul 21, 2008: Osmetech Announces Approval Of eSensor XT-8 Molecular Diagnostics Platform
  • 3.3 Clinical Trials
    • 3.3.1 May 13, 2009: Accumetrics Enrolls 1000th Patient Into GRAVITAS Trial
    • 3.3.2 Feb 26, 2009: Trimgen Corporation's eQPCR LC Warfarin Genotyping Kit Selected For NIH-Sponsored Trial To Determine Clinical Significance
    • 3.3.3 Nov 04, 2008: OraSure's Intercept Oral Fluid Drug Test Results Comparable To Urine Drug Screening According To Landmark Five-Year Analysis
    • 3.3.4 Jul 17, 2008: NicAlert Gains Acceptance In Clinical Trials And Research Studies: NicAlert Urine
    • 3.3.5 Jul 17, 2008: Nymox's NicAlert Gains Acceptance In Clinical Trials And Research Studies
• 4 Appendix
  • 4.1 Methodology
    • 4.1.1 Coverage
    • 4.1.2 Secondary Research
    • 4.1.3 Primary Research
    • 4.1.4 Expert Panel Validation
  • 4.2 Contact Us
  • 4.3 About Global Markets Direct
  • 4.4 Disclaimer
• 1 List of Tables
  • Table 1: Drug Related Testing Reagents Clinical Trial By Equipment Type
  • Table 2: Drug Related Testing Reagents Clinical Trials By Trial Phase and Trial Status
  • Table 3: Drug Related Testing Reagents Pipeline Products By Development Stage
  • Table 4: Drug Related Testing Reagents Pipeline Products By Therapy Area
  • Table 5: Drug Related Testing Reagents Pipeline Products By News Summary
• 1.2 List of Figures
  • Figure 1: Global Markets Direct Methodology